We make novel antibody medicines to treat cancers and rare diseases.
- Project: Onena Medicines & BTI. Proof of concept of the efficacy. Design of experiments using ONENA additive combined with PRGF in term of cell proliferation.
Articles related with Onena Medicines
808/11/2019
Announcing: 80 International Finalists for the 4th edition
BIND 4th Edition Finalists Today we are proud to announce the 80 Startup Finalists for the 4th and largest edition of Bind 4.0! These fine young companies come from 17 different countries and are well-suited to complement our Industry 4.0 Partners and the areas they plan to focus on, in [...]
2525/09/2019
The Results are In! 10% More Applicants in the 4th Edition of Bind 4.0 Accelerator Program
BIND 4th Edition Call Results More applicants than ever before! 577 Innovative Startups from around the world have applied for the 4th edition of Bind 4.0 Accelerator Program. Bind 4.0 has closed the registration period for its fourth call with a total of 577 candidates registered, which is an increase [...]
